Newsletter of MEDICA | View in browser | Deutsch | Print
Header of MEDICA Newsletter

New approaches in depression therapy

Dear Sir or Madam,

The start-up Syntropic Medical uses a new type of brain stimulation based on light. This non-invasive treatment shows strong potential in the treatment of mental disorders. In our interview, the company CEO, Mark Caffrey, explains how this technology promotes neuroplasticity by stimulating microglial cells and alleviates depressive symptoms. Preclinical studies show promising results.

Enjoy reading!

Tim Plato
Editorial team MEDICA-tradefair.com

Table of Contents
Interview: Syntropic Medical's promising non-invasive depression therapy
Newsletter Service

Lighting the way: Syntropic Medical's promising non-invasive depression therapy

Interview – MED TECH & DEVICES
Image: A man sits on a beige sofa with yellow cushions, arms crossed and looking down
The development of non-invasive treatments for mental health disorders has become increasingly significant. One such promising advancement comes from Syntropic Medical, led by founder Mark Caffrey. The start-up uses a new kind of brain stimulation that relies on light.
Click here for the interview
Lighting the way: Syntropic Medical's promising non-invasive depression therapy
Image: Banner with the text: Discover the world of MED TECH & DEVICES here; Copyright: Messe Düsseldorf
To top

Predicting cognitive progression in parkinson's patients

News

MED TECH & DEVICES
A recent study conducted by the University of the Basque Country (UPV/EHU) and Biobizkaia sheds light on a potential breakthrough in Parkinson's disease research. The study suggests that analyzing retinal thickness could serve as a predictive tool for cognitive progression in Parkinson's patients, offering new avenues for monitoring neurodegeneration.
read more
To top

Breakthrough transplant surgery: Heart pump and gene-edited pig kidney combined

News

MED TECH & DEVICES
NYU Langone Health has achieved a medical milestone with the first-ever combined mechanical heart pump and gene-edited pig kidney transplant surgery.
read more
To top

Fluorescence sensor for measuring oxygen in breathing air

News

MED TECH & DEVICES
The new sensor from Fraunhofer IPM measures the oxygen content in the air we breathe precisely and quickly, which significantly improves patient monitoring.
read more
To top

Newsletter Service

You like our newsletter? Then please recommend us: Forward this newsletter or the link www.MEDICA.de/news_login_2 to your friends and colleagues.

If you have difficulties with your order, please write an e-mail to redaktion@medica.de.
To top
Legal disclaimer

Messe Düsseldorf GmbH
Messeplatz, Stockumer Kirchstr. 61
40474 Düsseldorf, Germany

Phone: +49 211 4560-01
Fax: +49 211 4560-668
www.messe-duesseldorf.de
info@messe-duesseldorf.de

County Court Düsseldorf HRB 63

Board of Managing Directors: Wolfram N. Diener (Chairman), Marius Berlemann, Bernhard J. Stempfle

Chairman of Supervisory Board: Mayor Dr. Stephan Keller

Messe Düsseldorf GmbH processes personal data relating to you. You can find more information - also on your rights - in the privacy policy of Messe Düsseldorf GmbH available at www.messe-duesseldorf.de/privacy. In principle, i.e. subject to legal restrictions, you may at any time object to the processing of your personal data either on the aforementioned website, via e-mail to privacy@messe-duesseldorf.de or via postal mail to Messe Düsseldorf GmbH, G2-RV, PF 101006, 40001 Düsseldorf, Germany.

Facebook LinkedIn YouTube

Should you no longer wish to receive our newsletter, please click here.